Arora Sahej, Kharsa Adnan, Sharma Gaurav
Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.
Sands Constellation Heart Institute, Rochester General Hospital, Rochester, New York, USA.
JACC Case Rep. 2025 Aug 27;30(25):104755. doi: 10.1016/j.jaccas.2025.104755.
Familial hypercholesterolemia (FH) is a genetic condition characterized by high levels of low-density lipoprotein (LDL) and early atherosclerotic cardiovascular disease.
Our patient was a 61-year-old woman who had been referred to a cardiologist for LDL levels >200 mg/dL for more than a decade. She tested positive for a pathogenic LDLR mutation and was diagnosed with FH. She then underwent risk stratification with coronary computed tomography angiography and ultrasound of the carotid arteries, both of which showed no atherosclerotic disease. She continues to do well off statins.
Coronary artery calcifications can be seen as early as 11 to 23 years of age in patients with FH. Our patient did not have any evidence of atherosclerotic disease, nor did she have a family history of cardiovascular disease, and it was thought that she may have a protective factor affecting LDL metabolism.
TAKE-HOME MESSAGE: Patients with heterozygous FH can have absence of atherosclerosis despite lifelong severely elevated LDL levels.
家族性高胆固醇血症(FH)是一种遗传性疾病,其特征为低密度脂蛋白(LDL)水平升高以及早期动脉粥样硬化性心血管疾病。
我们的患者是一名61岁女性,十多年来因LDL水平>200mg/dL被转诊至心脏病专家处。她的致病性LDLR突变检测呈阳性,被诊断为FH。随后,她接受了冠状动脉计算机断层扫描血管造影和颈动脉超声检查进行风险分层,结果均显示无动脉粥样硬化疾病。她停用他汀类药物后情况依然良好。
FH患者早在11至23岁时就可出现冠状动脉钙化。我们的患者没有任何动脉粥样硬化疾病的证据,也没有心血管疾病家族史,据认为她可能有一种影响LDL代谢的保护因素。
杂合子FH患者尽管LDL水平终生严重升高,但可能没有动脉粥样硬化。